Table 4.
Results of in-vitro release studies of Naproxen.
| Formulation code | Lag time in hours (i.e. time taken for less than 10% of Naproxen release) | Mean % cumulative drug release at the end of 8 h | Mean % cumulative drug release at the end of 12 h |
|---|---|---|---|
| F1 | 2.01 ± 0.89 | 99.52 ± 0.82 | – |
| F2 | 2.12 ± 0.70 | 99.87 ± 0.90 | – |
| F3 | 2.36 ± 0.93 | 98.39 ± 0.44 | 99.86 ± 0.94+ |
| F4 | 2.42 ± 0.80 | 90.16 ± 0.76 | 99.73 ± 0.52 |
| F5 | 2.03 ± 0.66 | 99.95 ± 0.59 | – |
| F6 | 2.20 ± 1.07 | 99.80 ± 1.14 | – |
| F7 | 2.08 ± 0.59 | 99.74 ± 0.78 | – |
| F8 | 2.25 ± 1.15 | 98.60 ± 0.61 | 99.46 ± 0.70+ |
| F9 | 2.34 ± 0.61 | 97.10 ± 0.98 | 99.85 ± 0.83+ |
| F10 | 2.40 ± 0.98 | 91.92 ± 0.39 | 99.90 ± 0.95+ |
| F11 | 2.03 ± 0.74 | 99.97 ± 0.89∗ | – |
| F12 | 2.06 ± 0.96 | 98.61 ± 0.71∗ | – |
| F13 | 2.10 ± 0.80 | 99.57 ± 0.40∗ | – |
| F14 | 2.15 ± 0.79 | 99.86 ± 0.95∗ | – |
| F15 | 2.09 ± 0.94 | 99.10 ± 0.62∗ | – |
| F16 | 2.14 ± 0.67 | 99.47 ± 0.37 | – |
| F17 | 2.34 ± 1.10 | 99.69 ± 1.18 | – |
| F18 | 2.45 ± 0.97 | 92.59 ± 0.47 | 99.38 ± 0.69 |
| F19 | 2.11 ± 0.74 | 99.94 ± 1.07∗ | – |
| F20 | 2.27 ± 0.90 | 99.47 ± 0.36 | – |
| F21 | 2.32 ± 0.96 | 99.20 ± 0.54 | – |
| F22 | 2.24 ± 0.79 | 99.74 ± 0.86 | – |
| F23 | 2.26 ± 0.88 | 98.26 ± 0.73 | 99.88 ± 0.92+ |
| F24 | 2.21 ± 0.94 | 99.15 ± 0.66 | – |
Note: ∗Mark indicates that the Naproxen was released before 8 h.
+Mark indicates that the Naproxen was released before 12 h.